Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (201-210 of 311) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|April 7, 2009
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsKeith Wheatley, Cassandra L Brookes, Andrew J Howman, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Blood|April 14, 2010
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsDavid Grimwade, Robert K Hills, Anthony V Moorman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantationCharalampia Kyriakou, Carmen Canals, Jürgen Finke, et al.
Bone Marrow Transplantation|February 1, 1987
Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparisonC C Anderson, A H Goldstone, D C Linch, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II studyS H Lim, A C Newland, S Kelsey, et al.
Bone Marrow Transplantation|April 28, 1999
A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantationP D Kottaridis, H Rees, G Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trialAlan K Burnett, Robert K Hills, Donald W Milligan, et al.
British Journal of Haematology|December 21, 2000
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantationK S Peggs, W Preiser, P D Kottaridis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma GroupJ W Sweetenham, G Santini, W Qian, et al.
Pageof 32

Showing results (201-210 of 311) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|April 7, 2009
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsKeith Wheatley, Cassandra L Brookes, Andrew J Howman, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Blood|April 14, 2010
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsDavid Grimwade, Robert K Hills, Anthony V Moorman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantationCharalampia Kyriakou, Carmen Canals, Jürgen Finke, et al.
Bone Marrow Transplantation|February 1, 1987
Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparisonC C Anderson, A H Goldstone, D C Linch, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II studyS H Lim, A C Newland, S Kelsey, et al.
Bone Marrow Transplantation|April 28, 1999
A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantationP D Kottaridis, H Rees, G Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trialAlan K Burnett, Robert K Hills, Donald W Milligan, et al.
British Journal of Haematology|December 21, 2000
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantationK S Peggs, W Preiser, P D Kottaridis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma GroupJ W Sweetenham, G Santini, W Qian, et al.
Pageof 32